Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Auto injectors Market is expected to USD 5 Billion by 2024

Renub Research
Posted on: 15 Oct 18
Global Auto injectors Market is expected to USD 5 Billion by 2024

For More Information:


Get Free Customization in This Report

Auto injector is a medical device intended to deliver fixed doses of certain drugs. As to its name, auto injector automatically inserts the needle and performs the injection. Auto injectors have two types of design fillable or prefilled syringes. In the context of usability, auto injectors are available in disposable and re-usable form. Auto injectors are user friendly and are designed for self administration by any common people or patients. The market for auto injectors continues to grow significantly for the handy injection of a range of biotech products and anti-coagulants. Further, due to its handy nature, auto injectors are appreciated by a number of patients, who need a self injection. Global Auto injectors Market is expected to cross USD 5 Billion by the year 2024

Auto injectors have been in the market since 1990, however their usage were limited. During early days auto injectors were intended only to use in the emergency conditions such as epinephrine for treating anaphylactic shock (EpiPen). The first prefilled auto injector was introduced by Glaxo for treating migraine (Imigran/Imitrex) in the 1990s. The most common form of auto injectors available are pen injectors, because of its catridge system, which can be use for multiple doses. 


Request a free sample copy of the report:

Today, a major portion of global injectable drug delivery market growth is projected due to the extensive rise in the self administration of drug therapies, pushing the production of auto injectors such as EpiPen. The increase of self administration practice began at the behest of health insurance companies, which meant to reduce the expense and the number of physician office visits by facilitating patients to inject themselves with treatments for chronic health conditions like diabetes.


The needle tip of the auto injectors are kept protected prior to injection and have a passive safety lock to prevent accidental firing (injection). In addition, auto injectors also have an adjustable neddle function. Today, with pressing a button on auto injectors, the syringe needle gets automatically inserted in the patient’s body and the drug is delivered. Also, auto injectors come with a visual sign to confirm whether the dosage of drug has been administered correctly or not. With increasing advancement in technology, today the auto injectors are available in the size of a smartphone and can be put into a pocket.  This smartphone design auto injectors have automated voice instructions and retractable needle to assist their users on how to use the auto injectors properly. For example: ‘Auvi-Q’ epinephrine auto injector comes with this design. 



One of the big advantages of auto injectors are it is more important for the people with allergies. One can’t predict allergic reactions as it can be mild one time and serious the next. Also, an allergic attack can quickly become intense and may lead to anaphylaxis a severe life threatening reactions. An auto injector with a dose of epinephrine can treat anaphylaxis amazingly.

Auto injectors market is expected to grow considerably over the forecast period because of its self-administration features, which not only reduces the number of physician visits but also minimizes the drug delivery cost and time. Also, the growing incidence of anaphylaxis across the globe and notable reimbursement policy of government and health insurance companies help Auto Injectors market to grow remarkably over the forecast period (2018-2024).


Access full Research:

Market Summary

On the basis of application, Anaphylaxis has the highest market share in global auto injectors market. Multiple Sclerosis and Rheumatoid Arthritis are other segments covered in the report.

  • Based on product design types, Prefilled and Fillable two types of auto injectors are available in the market. Prefilled auto injector retains the majority share in this market place.
  • On the basis of Product Usability, Reusable and Disposable two types of auto injectors are available in the market. Disposable auto injector controls this market.
  • Based on distribution channel, report covers the auto injector market of Online Pharmacies and Retail Pharmacies. Online Pharmacy will drive the market in future.
  • Region-wise, North America has highest market share due to increasing prevalence of anaphylaxis. Other regions covered in the report are Asia Pacific, Middle East & Africa and Europe.
  • The competitive landscape of auto injectors market has also been studied with some of the key companies being Amgen Inc, Antares Pharma, Bayer AG, Mylan N.V and Novartis AG.


If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at


Key Topics Covered : 

1.    Executive Summary

2.    Global Auto-Injectors Market

3.    Market Share – Global Auto-Injectors

4.    Regions – Auto-Injectors Market

5.    Application - Auto-Injectors Market

6.    Product Type - Auto-Injectors Market

7.    Usability – Auto-Injectors Market

8.    Distribution Channels – Auto-Injectors Market

9.    Growth Drivers

10.    Challenges

11.    Antares Pharma, Inc – Company Analysis

12.    Mylan N.V. – Company Analysis

13.    Amgen Inc. – Company Analysis

14.    Novartis AG – Company Analysis

15.    Bayer AG – Company Analysis



Contact Us

Rajat Gupta

Sr. Marketing Manager


Phone: +1-678-302-0700


For more information:

Editor's Details

Rajat Gupta
Renub Research

Last updated on: 15/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.